biotechnology
News
Abbott 3Q profit jumps, outlook boostedAbbott Laboratories says its third-quarter profit jumped 51 percent, led by sales of the arthritis medication Humira.
The drug developer and medical device maker also raised its full-year outlook.
The company says it earned $1.08 billion, or 69 cents per share, compared with profit of $717 million, or 67 cents per share, during the same period a year earlier. Revenue rose 17.6 percent to just under $7.5 billion from $6.38 billion.
Excluding charges, the company says profit rose to 79 cents per share. Analysts polled by Thomson Financial expect profit of 77 cents per share on revenue of $7.35 billion.
Source : Topix.net | 15-Oct-2008 17:00
Par Pharmaceutical Announces Resizing of Generic Unit to Optimize Strong First-to-File Pipeline
Par Pharmaceutical Companies, Inc. today announced a resizing of its generic unit as part of an ongoing strategic assessment of its businesses.
Source : Topix.net | 15-Oct-2008 12:45
Ely Lilly Scoops Up ImClone
Carl Icahn got what he wanted: A major pharmaceutical company bought his biotech ImClone for more than the market thought it was worth.
Source : Topix.net | 15-Oct-2008 08:25
National health agency halts $9 mil. grant to Emory
Emory psychiatrist Dr. Charles B. Nemeroff is stepping down as principal researcher on several university projects funded by the National Institutes of Health.
Source : Topix.net | 15-Oct-2008 04:23
Genentech's 3rd-quarter profit rises 6.7 percent on cancer treatment sales, meets forecasts
's third-quarter profit fell rose 6.7 percent on sales of key cancer drugs, the biotechnology company said Tuesday, matching Wall Street's profit forecasts.
Source : Topix.net | 14-Oct-2008 23:26
Dow gauges worth of 30 US firms
NEW YORK - Amid weeks of stock market turmoil, many worried investors have been tracking the daily trajectory of the Dow Jones Industrial Average like never before.
Source : Topix.net | 14-Oct-2008 19:21
Johnson & Johnson 3Q profit rises, tops views
Health care giant Johnson & Johnson on Tuesday reported a 30 percent jump in third-quarter profit, beating Wall Street expectations, due to higher sales of consumer products and medical devices in the quarter ...
Source : Topix.net | 14-Oct-2008 15:08
Boston Scientific, Abbott stents tie in study
Abbott Laboratories' Xience and Boston Scientific Corp.'s Taxus Liberte, the newest entrants in the $1.9 billion US market for heart stents, dueled to a tie in a study of heart attack victims.
Source : Topix.net | 14-Oct-2008 10:59
Safety fears over arthritis dr...
Further fears about the safety of some pain-killing arthritis drugs have been raised after new evidence emerged of life-threatening risks associated with one of the medicines.
Source : Topix.net | 14-Oct-2008 06:50
Long-term study confirms Vioxx heart risks
A long-term analysis of people who took the arthritis drug Vioxx confirms it doubles the risk of strokes and heart attacks , researchers said on Monday, but this risk goes away a year after people stop taking ...
Source : Topix.net | 14-Oct-2008 02:42
King Pharmaceuticals extends offer for Alpharma stock
King Pharmaceuticals, Inc. today announced that it is extending its tender offer for all outstanding shares of Class A Common Stock of Alpharma Inc.
Source : Topix.net | 13-Oct-2008 22:24
Abbott Laboratories Plans to Buy Back as Much as $5 Billion of Its Shares
Abbott Laboratories said it will buy back as much as $5 billion in shares, driving the stock to its biggest gain in almost six years.
Source : Topix.net | 13-Oct-2008 18:14
FDA to Continue Review of Alogliptin NDA
PPD, Inc. today announced that Takeda Pharmaceutical Company Limited reported that Takeda Global Research and Development Center, Inc., a wholly owned U.S. subsidiary, received notification that the U.S. Food ...
Source : Topix.net | 13-Oct-2008 13:55
Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit...
Coughlin Stoia Geller Rudman & Robbins LLP today announced that a class action has been commenced on behalf of an institutional investor in the United States District Court for the District of Arizona on ...
Source : Topix.net | 13-Oct-2008 09:53
Presented By: IBM Web Conferencing ? Complimentary 14 Day Trial
 | Run better meetings online with Lotus Sametime Unyte. No downloads, no training ? and no need to call IT for help. Click to start your complimentary 14-day trial today. | |
Source : technologyreview.com | 13-Oct-2008 06:00
Baldness Genes
Finding the genetic causes could lead to new therapies for baldness.
Source : technologyreview.com | 13-Oct-2008 06:00
Omrix Biopharmaceuticals Provides Update On Fibrin Pad U.S. Phase II...
Oct 9, 2008 - Omrix Biopharmaceuticals, Inc. , a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, announced today that the Fibrin Pad U.S. Phase II ...
Source : Topix.net | 13-Oct-2008 05:34
Canadian Vaccine Manufacturer Able to Deliver Doses Ahead of Schedule
GlaxoSmithKline Inc. today announced that it has begun shipment of FLUVIRAL to Canadian private market customers for the 2008-2009 influenza season, having met and exceeded the contractual timelines for public ...
Source : Topix.net | 13-Oct-2008 01:20
Obama stock: Cardinal (CAH) delivers on health care promise
"Should Obama win the election, we would look towards select sub-sectors of health care; one stock we would expect to benefit is health supply distributor, Cardinal Health ," explains Kelley Wright , editor of ...
Source : Topix.net | 12-Oct-2008 21:18
San Diego man tucks 6 lobsters into his pants
A San Diego man who was allegedly poaching lobsters was caught with six of the creatures stuffed down his pants.
Source : Topix.net | 12-Oct-2008 17:14
Doctors, investors get latest data on heart devices
After years of controversy and concern over the safety and overuse of drug-coated heart stents, physicians and investors attending a cardiology meeting next week will get a clearer look at how these devices are ...
Source : Topix.net | 12-Oct-2008 12:57
Wockhardt in licensing deal with U.K. company
MUMBAI: Wockhardt has entered into an in-licensing agreement with Sinclair Pharma of the U.K. to market a range of dermatology and dental products.
Source : Topix.net | 12-Oct-2008 08:50
Biotech Stocks: Mylan, King lead drug stocks higher
Drug stocks advanced in early action Thursday, led by Mylan Laboratories and King Pharmaceuticals.
Source : Topix.net | 12-Oct-2008 04:40
Nation's Teen Vaccination Coverage Increasing
The nation's immunization coverage rates for preteens and teens are increasing for routinely recommended vaccines, but most still do not have all of the recommended immunizations, according to 2007 estimates ...
Source : Topix.net | 12-Oct-2008 00:29
Excaliard Appoints MD, President & Chief Executive Officer and Head of Clinical Operations
Excaliard Pharmaceuticals, a late stage preclinical company developing targeted therapeutics for the treatment of dermatological disorders and fibrotic diseases, is pleased to announce the appointment of ...
Source : Topix.net | 11-Oct-2008 20:12
Gene Logic and deSciner Enter into a Partnership to Create 'Genomics Gateway'
GAITHERSBURG, Md. & LEICESTER, England - Gene Logic has entered into a Strategic Alliance with deSciner Business Network to create an interactive genomics information resource.
Source : Topix.net | 11-Oct-2008 15:52
FDA Approves AstraZeneca's Seroquel XR for the Treatment of...
AstraZeneca today announced that the US Food and Drug Administration has approved once-daily SEROQUEL XR Extended-Release Tablets for the acute treatment of the depressive episodes associated with bipolar ...
Source : Topix.net | 11-Oct-2008 11:32
FDA Approves New Injection Site For RISPERDAL(R) CONSTA(R) For Schizophrenia Treatment
Alkermes, Inc. today announced that patients with schizophrenia now have a new administration option for RISPERDAL CONSTA [ Long-Acting Injection]. The U.S. Food and Drug Administration has approved a new ...
Source : Topix.net | 11-Oct-2008 07:27
Alabama Settles Suits Against Drug Companies
The state of Alabama has agreed to settle Medicaid drug pricing lawsuits it filed against prescription drug manufacturer Bristol Myers Squibb and four other companies.
Source : Topix.net | 11-Oct-2008 03:13
Report Targets Chronic Kidney Disease In US
A 30 percent increase in chronic kidney disease over the past decade has prompted the U.S. Renal Data System to issue for the first time a separate report documenting the magnitude of the disease, which affects ...
Source : Topix.net | 10-Oct-2008 22:53
Cambrex fined in plant explosion in Charles City
UNI mascot has your KWWL Storm Track Seven Forecast 911 tapes released in Monday's plane crash Jones homecoming ceremony to help flood victims Flu Shot season is here Economy hits Iowa budget Jumpstart Iowa ...
Source : Topix.net | 10-Oct-2008 18:48
Alfacell's ONCONASE targets siRNA
The paper is the result of research conducted by collaborators at the Brander Cancer Research Institute and Department of Pathology at New York Medical College and Alfacell.
Source : Topix.net | 10-Oct-2008 14:42
Watson Receives Us Fda Approval for Rapaflo(TM) (silodosin) for the...
Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has approved RAPAFLO , the company's new alpha blocker for the treatment of ...
Source : Topix.net | 10-Oct-2008 10:35
Lilly to Acquire ImClone for $6.5 billion
Under a definitive merger agreement, Eli Lilly and Company will acquire ImClone Systems in a cash tender offer of approximately $6.5 billion.
Source : Topix.net | 10-Oct-2008 06:17
Biovail faces new shareholders' class action suit
A group of American investors has launched a class-action lawsuit against drug maker Biovail Corp., alleging that company and some executives made misleading statements during the approval process for the ...
Source : Topix.net | 10-Oct-2008 02:00
1 in 4 U.S. teen girls get cervical cancer shot
ATLANTA: About one in four teen girls last year got the groundbreaking vaccine that prevents cervical cancer, federal health officials reported today.
Source : Topix.net | 09-Oct-2008 21:48
deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for ...
Enables women to understand whether they may benefit from more intensive screening, monitoring or preventive drug therapy REYKJAVIK, Iceland , Oct.
Source : Topix.net | 09-Oct-2008 17:42
Boston Scientific Announces Third Quarter Adjustments
Boston Scientific announced today it expects to record the following adjustments to its third quarter results, which it plans to report on October 23rd.
Source : Topix.net | 09-Oct-2008 13:39
Novel Lung Cancer Vaccine Trial Launched at UCSD
Oncologists at the Moores Cancer Center at the University of California, San Diego in La Jolla are hoping to stave off the relentless march of advanced lung cancer by treating patients with a novel kind of ...
Source : Topix.net | 09-Oct-2008 09:28
A Source of Men's Stem Cells
Stem cells from human testes could be used for personalized medicine.
Source : technologyreview.com | 09-Oct-2008 06:00
Lawsuit claims Pfizer massaged Neurontin studies
LONDON (Reuters) - Pfizer Inc tried to suppress medical studies that did not support the use of its epilepsy drug Neurontin, internal Pfizer documents submitted in a U.S. lawsuit against the company showed.
The documents suggest that Pfizer's marketers influenced Neurontin's scientific record to boost sales at least until 2003 by delaying the publication or altering the conclusions of studies that had found no evidence the drug worked for various conditions besides epilepsy.
Pfizer, the world's biggest drugmaker, denied the charges. "Pfizer is committed to the communication of medically or scientifically significant results of all studies, regardless of outcome," a company spokesman said in a statement.
Source : Topix.net | 09-Oct-2008 05:25
Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance
The original agreement between the companies, announced in February 2007, was to develop innovative, nanotechnology-based products and solutions based on Merck's materials.
Source : Topix.net | 09-Oct-2008 01:11
Delaware is in line for nearly $1 million as part of a $62 million...
Delaware is in line for nearly $1 million as part of a $62 million settlement with drugmaker Eli Lilly & Co.
Source : Topix.net | 08-Oct-2008 20:58
Man Sued In NYC Over 25-Foot 'Viva Viagra' Rocket
Oct 8, 2008 6:39 am US/Eastern Man Sued In NYC Over 25-Foot 'Viva Viagra' Rocket NEW YORK A New York man is being sued for trademark infringement after he towed a 25-foot-long fake missile around Manhattan with ...
Source : Topix.net | 08-Oct-2008 16:42
AtheroGenics Files for Chapter 11 Bankruptcy
Oct 7, 2008 -- AtheroGenics, Inc. , a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it has consented to the Involuntary Chapter 7 Petition filed against ...
Source : Topix.net | 08-Oct-2008 12:33
Idaho company trims search for uranium gas plant site
A small eastern Idaho company aiming to build a $55 million plant to extract industrial gases from depleted uranium somewhere in the West has narrowed its search to four sites, including two in Idaho where ...
Source : Topix.net | 08-Oct-2008 08:32